Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹9.67Admitted-Finance 128 5 VISHWAS NAGAR EAST DELHI DELHI 110032 | SHAHDARA | DELHI | 110032 | ₹9.67 | L1 | Admitted-Finance |
| 2 | Rejected-Technical | - | - | Rejected-Technical Not as per DNIT |
| 3 | Rejected-Technical | - | - | Rejected-Technical Not as per DNIT |
| Sl No | Description | Qty | Unit | MEDIPOL PHARMACEUTICAL iNDIA pVT. lTD L1 |
|---|---|---|---|---|
| 1.00 | Voglibose 0.3 mg + Metformin 500mg + Glimipride 1 mg Tablet | 1 | Item1 | - |
| 2.00 | Sunscreen Lotion SPF 26,100ml bottle | 1 | Item2 | - |
| 3.00 | Clotrimazole 1% w/v + lignocaine Hydrochloride 2% w/v Ear Drops, 5ml Bottle | 1 | Item3 | 9.21 ₹9.67 Lowest |
| 4.00 | Dioctyl Sulfosuccinate sodium liquid,100 ml | 1 | Item4 | - |
| 5.00 | Hydroquinone 4%+ tretinoin 0.05% +Fluocinolone 0.01 % skin cream, 15gm tube | 1 | Item5 | - |
| 6.00 | Diltizem Hydrochloride Tablet 30 mg (Modified Release) | 1 | Item6 | - |
| 7.00 | Levitiracetam Oral Solution, 100mg/ml, 100ml Bottle | 1 | Item7 | - |
| 8.00 | Natamycin Eye Drops 2%, 5 ml | 1 | Item8 | - |
| 9.00 | Tropicamide + Phenylepherine Eye Drops 0.8% + 5%, 5 ml vial | 1 | Item9 | - |
| 10.00 | Mirabegron Tablet 50 mg | 1 | Item10 | - |
Tender Value
₹7.9 Cr
EMD Value
₹2 L
Closing Date
10 Oct 2025, 1:00 pmClosed
MD, HMSCL
MD, HMSCL, Plot No. 9, DHL Square, 5th Floor, Panchkula
Online Tender for the Rate Contract for the supply of Medicine to Various Hospitals of Government of Haryana for a Period of Two Years for Group B Medicines
2025_HBC_471061_1
354/Tend/GPB/2025-26/3/4-A
Open Tender
Miscellaneous Goods
Item-rate/Agreement basic
60 days
MD, HMSCL, 9 DHL Square, 5th Floor, Sec-22, PKL
Please refer the tender document
2 documents required · 2 mandatory
₹5,000
Yes
₹2 L
Yes
8 Dec 2025
10 Sept 2025
10 Oct 2025
10 Sept 2025
10 Oct 2025
10 Sept 2025
10 Sept 2025 - 17 Sept 2025
Voglibose 0.3 mg + Metformin 500mg + Glimipride 1 mg Tablet
Sunscreen Lotion SPF 26,100ml bottle
Clotrimazole 1% w/v + lignocaine Hydrochloride 2% w/v Ear Drops, 5ml Bottle
Dioctyl Sulfosuccinate sodium liquid,100 ml
Hydroquinone 4%+ tretinoin 0.05% +Fluocinolone 0.01 % skin cream, 15gm tube
Diltizem Hydrochloride Tablet 30 mg (Modified Release)
Levitiracetam Oral Solution, 100mg/ml, 100ml Bottle
Natamycin Eye Drops 2%, 5 ml
Tropicamide + Phenylepherine Eye Drops 0.8% + 5%, 5 ml vial
Mirabegron Tablet 50 mg
Podophylline Resin Topical Solution 25%, 10 ml bottle
Breviteracetam Tablet 50 mg
Acylovir Eye Oint 5%, 5 gm
Temozolamide Tablet 250 mg
Diacerein 50 mg + Glucosamine Sulphate 750 mg Tablet
Cariprazine Tablet 1.5 mg
Homatropine Eye Drops 1%, 5 ml
Temozolamide Tablet 100 mg
Boro-spirit ear drops, 3% W/V Ear Drops 10 ml
Simethicone Syrup 40mg, 60 ml Bottle
Midazolam Nasal Spray 1.25 mg/spray
Caffeine Citrate oral solution 20 mg/ml, 3ml
Cyclopentolate Eye Drops 1% w/v
Activated Charcoal Tablet 500 mg
Nicotin Chewgum 4 mg
Cabergoline Tablet 0.5 mg
Methylphenidate Tablet 5 mg
Methyldopa Tablet 250 mg
Vortioxetine Tablet 10 mg
Nicotin Chewgum 2 mg
Glyceryl trinitrate (sublingual) Tablet 500 micrograms
Melatonin Tablet 3 mg
Lacosamide Tablet 100 mg
Phenytoin Oral solution 25 mg/ml, 100 ml glass bottle
Mifepristone Tablet 25 mg
Sertraline Tablet (SR) 50 mg
Ethinyestradiol Tablet 5 mcg
Acyclovir Eye Ointment 3%, 4.5 gm tube
Conjugated Estrogen Tablet 0.625 mg
Prochlorperazine Mouth Dissolving Tablet flavored base 5mg
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.50 MB
BOQ_548950.xls
BOQ • 0.30 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .